{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:39:52Z","timestamp":1792805992153,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"RA-HDHL Project AMBROSIAC"},{"name":"ondazione Ente Cassa di Risparmio Firenze"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biopha.2020.110368","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:37:34Z","timestamp":1592267854000},"page":"110368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice"],"prefix":"10.1016","volume":"129","author":[{"given":"Adriano","family":"Lama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Provensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-3631","authenticated-orcid":false,"given":"Roberta","family":"Amoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-7021","authenticated-orcid":false,"given":"Barbara","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pina","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Mattace","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7812-9029","authenticated-orcid":false,"given":"Clara","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7729-9069","authenticated-orcid":false,"given":"Maria Beatrice","family":"Passani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/10409238.2015.1092944","article-title":"Macrophage-derived lipid agonists of PPAR-\u03b1 as intrinsic controllers of inflammation","volume":"51","author":"Pontis","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"32","key":"10.1016\/j.biopha.2020.110368_bib0010","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","article-title":"Gut-brain axis: role of lipids in the regulation of inflammation, pain and CNS diseases","volume":"25","author":"Russo","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2020.110368_bib0015","doi-asserted-by":"crossref","first-page":"34611","DOI":"10.1038\/srep34611","article-title":"Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPAR\u03b1 signaling and inhibiting the NF-\u03baB and ERK1\/2\/AP-1\/STAT3 pathways","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2020.110368_bib0020","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1074\/jbc.M607809200","article-title":"Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine","volume":"282","author":"Fu","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110368_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037729","article-title":"Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids","volume":"7","author":"Su\u00e1rez","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0030","doi-asserted-by":"crossref","first-page":"14881","DOI":"10.1038\/s41598-018-32925-x","article-title":"Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer\u2019s patches of mice","volume":"8","author":"Di Paola","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised controlled trial of mesalazine in IBS","volume":"65","author":"Barbara","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0040","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41598-019-38865-4","article-title":"Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer","volume":"9","author":"Grill","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110368_bib0045","doi-asserted-by":"crossref","first-page":"G1328","DOI":"10.1152\/ajpgi.00467.2004","article-title":"Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: correlation between symptoms and inflammation","volume":"288","author":"Melgar","year":"2005","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110368_bib0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ijnp\/pyw110","article-title":"Histaminergic neurotransmission as a gateway for the cognitive effect of oleoylethanolamide in contextual fear conditioning","volume":"20","author":"Provensi","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2020.110368_bib0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuropharm.2018.03.033","article-title":"Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide","volume":"135","author":"Costa","year":"2018","journal-title":"Neuropharmacology"},{"issue":"Pt A","key":"10.1016\/j.biopha.2020.110368_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2016.08.020","article-title":"The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice","volume":"113","author":"Umehara","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"31","key":"10.1016\/j.biopha.2020.110368_bib0065","doi-asserted-by":"crossref","first-page":"11527","DOI":"10.1073\/pnas.1322016111","article-title":"Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake","volume":"111","author":"Provensi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.biopha.2020.110368_bib0070","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/bph.13637","article-title":"An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis","volume":"174","author":"Simeoli","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0075","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1038\/s41598-019-41295-x","article-title":"N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition","volume":"9","author":"Lama","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2020.110368_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110368_bib0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cgh.2013.07.001","article-title":"Intestinal permeability defects: is it time to treat?","volume":"11","author":"Odenwald","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110368_bib0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1189\/jlb.0911485","article-title":"Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice","volume":"91","author":"Di Paola","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110368_bib0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00018-012-1070-x","article-title":"Regulation of intestinal epithelial permeability by tight junctions","volume":"70","author":"Suzuki","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"41","key":"10.1016\/j.biopha.2020.110368_bib0100","doi-asserted-by":"crossref","first-page":"27952","DOI":"10.1074\/jbc.M109.046292","article-title":"AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function","volume":"284","author":"Scharl","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110368_bib0105","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ajpath.2015.12.016","article-title":"TNF-\u03b1 Modulation of intestinal tight junction permeability is mediated by NIK\/IKK-\u03b1 axis activation of the canonical NF-\u03baB pathway","volume":"186","author":"Al-Sadi","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110368_bib0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1753425909339231","article-title":"Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis","volume":"16","author":"Vamadevan","year":"2010","journal-title":"Innate Immune"},{"issue":"6913","key":"10.1016\/j.biopha.2020.110368_bib0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01180","article-title":"The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors","volume":"420","author":"Horng","year":"2002","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.biopha.2020.110368_bib0120","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.3748\/wjg.14.5149","article-title":"Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory","volume":"14","author":"Levin","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110368_bib0125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10620-010-1240-3","article-title":"Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis","volume":"56","author":"Hall","year":"2011","journal-title":"Dig. Dis. Sci."},{"issue":"24","key":"10.1016\/j.biopha.2020.110368_bib0135","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1111\/bph.14501","article-title":"Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide","volume":"175","author":"Ant\u00f3n","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110368_bib0140","doi-asserted-by":"crossref","first-page":"G488","DOI":"10.1152\/ajpgi.00023.2009","article-title":"Role of peroxisome proliferator-activated receptor-alpha in ileum tight junction alteration in mouse model of restraint stress","volume":"297","author":"Mazzon","year":"2009","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"10.1016\/j.biopha.2020.110368_bib0145","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/932530","article-title":"Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis","volume":"2014","author":"Yamamoto-Furusho","year":"2014","journal-title":"Dis. Markers"},{"issue":"12","key":"10.1016\/j.biopha.2020.110368_bib0150","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/labinvest.3700185","article-title":"Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice","volume":"84","author":"Cuzzocrea","year":"2004","journal-title":"Lab. Invest."},{"issue":"10","key":"10.1016\/j.biopha.2020.110368_bib0155","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.intimp.2010.07.007","article-title":"PPAR\u03b1 contributes to colonic protection in mice with DSS-induced colitis","volume":"10","author":"Azuma","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110368_bib0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.12907","article-title":"Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent","volume":"172","author":"Borrelli","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110368_bib0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.201500132","article-title":"Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPAR\u03b1","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2020.110368_bib0170","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.1002\/jcp.28474","article-title":"Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1\/AMPK activation","volume":"234","author":"Yao","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110368_bib0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2020.110368_bib0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/dom.13062","article-title":"Therapeutic application of GPR119 ligands in metabolic disorders","volume":"20","author":"Yang","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2020.110368_bib0185","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1476-5381.2011.01754.x","article-title":"Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways","volume":"165","author":"Lan","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110368_bib0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.07.015","article-title":"Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds","volume":"812","author":"Insuela","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110368_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110368_bib0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.gdata.2015.06.031","article-title":"Transcriptome analysis of TH2 CD4(+) T cells differentiated from wild-type and NLRP3KO mice","volume":"5","author":"Bruchard","year":"2015","journal-title":"Genom Data"},{"key":"10.1016\/j.biopha.2020.110368_bib0205","article-title":"Host-microbiota interactions in inflammatory bowel disease","author":"Neurath","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110368_bib0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tem.2013.03.001","article-title":"A fatty gut feeling","volume":"24","author":"Piomelli","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2020.110368_bib0215","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041084","article-title":"Extra-virgin olive oil from apulian cultivars and intestinal inflammation","volume":"12","author":"Cariello","year":"2020","journal-title":"Nutrients"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:58:00Z","timestamp":1760097480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220305618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"alternative-id":["S0753332220305618"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110368","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110368"}}